AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
AAC Accepts, published online ahead of print on 21 May 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.00412-07v1
51/8/2784    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taha, M.-K.
Right arrow Articles by Zarantonelli, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taha, M.-K.
Right arrow Articles by Zarantonelli, M. L.

 Previous Article  |  Next Article 

Antimicrob. Agents Chemother. doi:10.1128/AAC.00412-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Target gene sequencing to characterize penicillin G susceptibility of Neisseria meningitidis

Muhamed-Kheir Taha*, Julio A. Vázquez*, Eva Hong, Desiree E Bennett, Sophie Bertrand, Suzana Bukovski, Mary T Cafferkey, Françoise Carion, Jens Jørgen Christensen, Mathew Diggle, Giles Edwards, Rocío Enríquez, Cecilia Fazio, Matthias Frosch, Sigrid Heuberger, Steen Hoffmann, Keith A. Jolley, Marcin Kadlubowski, Amel Kechrid, Konstantinos Kesanopoulos, Paula Kriz, Lotte Lambertsen, Ileanna Levenet, Martin Musilek, Metka Paragi, Aouatef Saguer, Anna Skoczynska, Paola Stefanelli, Sara Thulin, Georgina Tzanakaki, Magnus Unemo, Ulrich Vogel, and Maria Leticia Zarantonelli

Neisseria Unit, Institut Pasteur, Paris, France; Reference Laboratory for Neisserias. National Center for Microbiology. Institute of Health Carlos III. Majadahonda (Madrid), Spain; Epidemiology and Molecular Biology Unit and Irish Meningococcal and Meningitis Reference Laboratory, The Children's University Hospital, Dublin, Ireland; National Reference Centre for Neisseria meningitidis, Bacteriology division, Scientific Institute of Public Health, Brussels, Belgium; University Hospital for Infectious Diseases, Zagreb, Croatia; Neisseria and Streptococcus Reference laboratory, Statens Serum Institut, Copenhagen, Denmark; Scottish Meningococcus and Pneumococcus Reference Laboratory, Stobhill Hospital Glasgow, United Kingdom; Dept. of Infectious, Parasitic & Immune-mediated Diseases, Istituto Superiore di Sanità, Rome, Italy; Institute for Hygiene and Microbiology, National Reference Center for Meningococci, University of Würzburg, Germany; National Reference Centre for Meningococci, Austrian Agency for Health and Food Safety, Graz, Austria; Peter Medawar Building and Department of Zoology, University of Oxford, United Kingdom; National Reference Centre for Bacterial Meningitis, National Medicine Institute, Warsaw, Poland; Hôpital d'Enfants, Tunis, Tunisia; National Meningitis Reference Laboratory, National School of Public Health, Athens, Greece; National Reference Laboratory for Meningococcal Infections, National Institute of Public Health, Prague, Czech Republic; Cantacusino Institute, Bucharest, Romania; Institute of Public Health, Communicable Diseases Centre, Ljubljana, Slovenia; National Reference Laboratory for Pathogenic Neisseria, Örebro University Hospital, Örebro, Sweden

* To whom correspondence should be addressed. Email: mktaha{at}pasteur.fr. jvazquez{at}isciii.es.


   Abstract

Clinical isolates of Neisseria meningitidis with reduced susceptibility to penicillin G (intermediate isolates, PenI) harbor alterations in the penA gene encoding the penicillin binding protein 2 (PBP2). A 402 bp DNA fragment in the 3' half of penA was sequenced from a collection of 1670 meningococcal clinical isolates from 22 countries that spanned 60 years. Phenotyping, genotyping and determination of minimal inhibitory concentrations to penicillin G were also performed. A total of 139 different penA alleles were detected with 38 alleles that were highly related, clustered together in maximum likelihood analysis and corresponded to the penicillin G susceptible isolates. The remaining 101 penA alleles were highly diverse, corresponded to different genotypes/phenotypes and accounted for 38% of isolates, but no clonal expansion was detected. Analysis of the altered alleles that were represented by at least five isolates showed high correlation with PenI phenotype. The deduced amino acid sequence of the corresponding PBP2 comprised five amino acid residues that were always altered. This correlation was not complete for rare alleles suggesting that other mechanisms may also be involved in conferring reduced susceptibility to penicillin. Evidence of mosaic structures through events of interspecies recombination was also detected in altered alleles. A new web site was created based on the data from this work (http://neisseria.org/nm/typing/penA). These data argue for the use of penA sequencing to identify isolates with reduced susceptibility to penicillin G and as a tool to improve typing of meningococcal isolates as well as to analyze DNA exchange among Neisseria species.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.